[{"data":1,"prerenderedAt":122},["ShallowReactive",2],{"drug-bisoprolol":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":20,"formulations":25,"regimens":57,"contraindications":99,"warnings":109,"renal":110,"monitoring":111,"interactions":112,"review":113,"examples":116},"bisoprolol",1,{"fa":7,"en":8},"بیزوپرولول","Bisoprolol","cardiovascular",{"fa":11,"en":12},"بتابلاکر انتخابی β1","Beta-1 selective blocker",[14,17],{"name":15,"market":16},"Zebeta","US",{"name":18,"market":19},"Concor","GB",[21,22,23,24,7],"zebeta","concor","کنکور","بیسوپرولول",[26,40,49],{"id":27,"form":28,"route":29,"label":30,"concentration":31,"markets":35,"refs":36},"tab-2-5","tablet","oral","2.5 mg tablet",{"amount":32,"unit":33,"perUnit":28,"scored":34},2.5,"mg",false,[16],[37],{"source":38,"section":39},"fda-bisoprolol","How Supplied",{"id":41,"form":28,"route":29,"label":42,"concentration":43,"markets":46,"refs":47},"tab-5","5 mg tablet (scored)",{"amount":44,"unit":33,"perUnit":28,"scored":45},5,true,[16],[48],{"source":38,"section":39},{"id":50,"form":28,"route":29,"label":51,"concentration":52,"markets":54,"refs":55},"tab-10","10 mg tablet",{"amount":53,"unit":33,"perUnit":28,"scored":34},10,[16],[56],{"source":38,"section":39},[58,84],{"id":59,"disease":60,"label":61,"population":64,"type":68,"unit":33,"dose":69,"refs":70,"limits":73,"notes":77},"htn","hypertension",{"fa":62,"en":63},"فشار خون — ۵ mg یک بار در روز","Hypertension — 5 mg once daily",{"minAge":65},{"value":66,"unit":67},18,"year","fixed",{"perDose":44,"dosesPerDay":5},[71],{"source":38,"section":72},"Dosage and Administration",{"maxPerDay":74,"refs":75},20,[76],{"source":38,"section":72},[78],{"text":79,"refs":82},{"fa":80,"en":81},"گاهی شروع ۲٫۵ mg (برونکواسپاسم). افزایش به ۱۰ و سپس ۲۰ mg. نارسایی کبد یا CrCl کمتر از ۴۰: شروع ۲٫۵ mg.","Some patients start 2.5 mg (bronchospasm). Increase to 10 then 20 mg. Hepatic impairment or CrCl \u003C40: start 2.5 mg.",[83],{"source":38,"section":72},{"id":85,"disease":60,"label":86,"population":89,"type":91,"unit":33,"dose":92,"refs":96},"peds",{"fa":87,"en":88},"زیر ۱۸ سال","Under 18 years",{"maxAge":90},{"value":66,"unit":67},"notCalculated",{"reason":93},{"fa":94,"en":95},"بی‌خطری و اثربخشی در کودکان ثابت نشده است.","Safety and effectiveness in children not established.",[97],{"source":38,"section":98},"Pediatric Use",[100],{"id":101,"severity":102,"text":103,"refs":106},"ci","block",{"fa":104,"en":105},"شوک کاردیوژنیک، نارسایی قلبی آشکار، بلوک AV درجه ۲ یا ۳، برادی‌کاردی سینوسی شدید.","Cardiogenic shock, overt cardiac failure, second- or third-degree AV block, marked sinus bradycardia.",[107],{"source":38,"section":108},"Contraindications",[],[],[],[],{"status":114,"reviewer":115,"date":115},"unverified",null,[117],{"regimen":59,"formulation":41,"input":118,"expect":121},{"ageYears":119,"weightKg":120},50,80,{"perDose":44},1792078532197]